01:19 PM EDT, 06/30/2025 (MT Newswires) -- INmune Bio ( INMB ) said its phase 2 clinical trial of XPro in patients with early Alzheimer's disease and biomarkers of inflammation failed to meet its primary cognitive endpoint.

Shares plunged 60% as intraday trading volume rose to over 27.5 million from a daily average of about 1.5 million.

Ostin Technology ( OST ) said Monday it launched a registered direct offering of about 41.7 million Class A ordinary shares at $0.12 per share, targeting gross proceeds of roughly $5 million.

Shares slumped 55% as intraday trading volume rose to over 107.6 million from a daily average of about 8.2 million.

Fortive ( FTV ) and Ralliant said they have completed their separation as of Saturday, with Fortive ( FTV ) spinning off its precision technologies segment as a new publicly traded company.

Shares of Fortive ( FTV ) dropped 4.6% intraday, with trading volume rising to more than 4.4 million from a daily average of about 3.3 million.

Price: 2.13, Change: -3.20, Percent Change: -60.04